BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24500397)

  • 1. Toxic excipients in medications for neonates in Brazil.
    Souza A; Santos D; Fonseca S; Medeiros M; Batista L; Turner M; Coelho H
    Eur J Pediatr; 2014 Jul; 173(7):935-45. PubMed ID: 24500397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
    de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
    BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
    Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
    Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalised neonates in Estonia commonly receive potentially harmful excipients.
    Lass J; Naelapää K; Shah U; Käär R; Varendi H; Turner MA; Lutsar I
    BMC Pediatr; 2012 Aug; 12():136. PubMed ID: 22931304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially harmful excipients in neonatal medicines: a pan-European observational study.
    Nellis G; Metsvaht T; Varendi H; Toompere K; Lass J; Mesek I; Nunn AJ; Turner MA; Lutsar I;
    Arch Dis Child; 2015 Jul; 100(7):694-9. PubMed ID: 25854872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially harmful excipients in neonatal medications: a multicenter nationwide observational study in Japan.
    Saito J; Nadatani N; Setoguchi M; Nakao M; Kimura H; Sameshima M; Kobayashi K; Matsumoto H; Yoshikawa N; Yokoyama T; Takahashi H; Suenaga M; Watanabe R; Imai K; Obara M; Hashimoto M; Yamamoto K; Fujiwara N; Sakata W; Nagai H; Enokihara T; Katayama S; Takahashi Y; Araki M; Iino K; Akiyama N; Katsu H; Fushimi K; Takeda T; Torimoto M; Kishi R; Mitsuya N; Kihara R; Hasegawa Y; Hamada Y; Kimura T; Wada M; Tanzawa A; Yamatani A
    J Pharm Health Care Sci; 2021 Jul; 7(1):23. PubMed ID: 34193299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia.
    Sviestina I; Mozgis D
    Eur J Hosp Pharm; 2018 Jul; 25(4):176-182. PubMed ID: 31157015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cumulative Daily Tolerance Levels of Potentially Toxic Excipients Ethanol and Propylene Glycol Are Commonly Exceeded in Neonates and Infants.
    Valeur KS; Hertel SA; Lundstrøm KE; Holst H
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):523-530. PubMed ID: 29281181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of off-label and unlicensed drugs in the neonatal intensive care unit and its association with severity scores.
    Carvalho CG; Ribeiro MR; Bonilha MM; Fernandes M; Procianoy RS; Silveira RC
    J Pediatr (Rio J); 2012; 88(6):465-70. PubMed ID: 23108602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia.
    Fister P; Urh S; Karner A; Krzan M; Paro-Panjan D
    J Matern Fetal Neonatal Med; 2015; 28(17):2053-61. PubMed ID: 25316561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to potentially harmful excipients in medications among neonates at a state hospital in Malaysia.
    Wong SW; Chew SP; Abdul Aziz SA; Mohamed Shah N
    Drug Dev Ind Pharm; 2024 Mar; ():1-9. PubMed ID: 38459761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil.
    Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
    BMJ Open; 2019 Jul; 9(7):e024377. PubMed ID: 31296505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit.
    Girardi A; Galletti S; Raschi E; Koci A; Poluzzi E; Faldella G; De Ponti F
    Ital J Pediatr; 2017 Apr; 43(1):37. PubMed ID: 28412957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury in neonatal intensive care: Medicines involved.
    Safina AI; Daminova MA; Abdullina GA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S9-S10. PubMed ID: 26639729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excipient exposure in very low birth weight preterm neonates.
    Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
    J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of In-hospital Neonatal Death in the Tertiary Neonatal Intensive Care Unit in China: A Multicenter Retrospective Study.
    Wang CH; Du LZ; Ma XL; Shi LP; Tong XM; Liu H; Ding GF; Yi B; Pan XN; Zhong DN; Liu L; Li M; Liu CQ; Xia SW; Wang HY; He L; Liang K; Zhou XY; Han SP; Lyu Q; Qiu YP; Shan RB; Mu DZ; Liu XH; Zhuang SQ; Guo J; Liu L; Zhu JJ; Xiong H
    Chin Med J (Engl); 2016 Nov; 129(22):2652-2658. PubMed ID: 27823995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
    Saito J; Nakamura H; Akabane M; Yamatani A
    Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.